PCI: protein C inhibitor?
Cooper
S T
ST
Department of Biology and Microbiology, University of Wisconsin-La Crosse 54601, USA.
Church
F C
FC
D000818:Animals; D001665:Binding Sites; D001777:Blood Coagulation / Q000502:physiology*; D001943:Breast Neoplasms / Q000503:physiopathology; D005260:Female; D006025:Glycosaminoglycans / Q000378:metabolism; D006493:Heparin / Q000378:metabolism; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000503:physiopathology; D011486:Protein C / Q000037:antagonists & inhibitors / Q000378:metabolism*; D018046:Protein C Inhibitor / Q000737:chemistry* / Q000378:metabolism* / Q000494:pharmacology; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology
D006025:Glycosaminoglycans; D011486:Protein C; D018046:Protein C Inhibitor; D011994:Recombinant Proteins; D006493:Heparin